6505--Base 4 Supply - 503B Compounding Products - MPLS
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
NETWORK CONTRACT OFFICE 23 (36C263)
Contract Value
Not provided
Codes & Classification
Solicitation Number
36C26325Q1115
NAICS
325412 - Pharmaceutical Preparation Manufacturing
Classification Code
6505
Additional Details
Documents3
The Network Contract Office 23 (NCO 23), a federal office operating under the U.S. Department of Veterans Affairs, has issued Solicitation 36C26325Q1115 for the procurement of 503B compounding pharmaceutical products, designated as "Base 4 Supply." This solicitation seeks to establish a reliable supply of compounded medications in accordance with the requirements of 503B outsourcing facilities, ensuring compliance with FDA regulations and quality standards for pharmaceutical preparation.
The scope of this procurement encompasses the manufacturing and delivery of pharmaceutical preparations, as classified under NAICS Code 325412 (Pharmaceutical Preparation Manufacturing, 2022 version) and Product Service Code 6505. The intended outcome is to secure high-quality compounded products that support the medical and operational needs of the VA facilities served by NCO 23, with a focus on safety, efficacy, and regulatory compliance.
Key requirements for this opportunity include the ability to provide 503B compounded products that meet all applicable federal standards and guidelines. Contractors must demonstrate expertise in pharmaceutical manufacturing, particularly in the compounding of sterile and non-sterile preparations, and maintain appropriate certifications and quality assurance protocols. Deliverables are expected to include timely and consistent supply of specified compounded medications, with documentation and traceability as required by federal regulations.
The contracting entity for this solicitation is the Network Contract Office 23 (NCO 23), identified by organization key 100183219. Interested parties should direct inquiries and submissions to the primary contact, Traci A Johannes, at [email protected]. The solicitation was posted on November 19, 2025, and responses are due by December 1, 2025, at 22:12. The notice remains active and is accessible via the official SAM.gov portal at https://sam.gov/opp/27c0ec4b8d7f42eca4094048baba4761/view, where three attachments are available for further review.
This procurement is classified as a solicitation, and contractors should review all posted documentation for specific instructions regarding proposal submission, evaluation criteria, and any set-aside requirements. No special set-aside or socioeconomic considerations are indicated in the provided information. Contractors with proven capabilities in pharmaceutical preparation manufacturing, particularly those experienced with 503B compounding, are encouraged to assess this opportunity for alignment with their expertise and operational capacity.
Overall, this solicitation represents a significant opportunity to support the VA’s mission by supplying critical compounded pharmaceutical products, with an emphasis on regulatory compliance, quality assurance, and reliable delivery throughout the contract lifecycle.